Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Enlivex Therapeutics and Unusual Machines Inc. will be featured on the RedChip Small Stocks, Big Money™ show on Bloomberg TV. Enlivex Therapeutics, led by CEO Oren Hershkovitz, offers a promising investment opportunity in the biopharmaceutical sector with its innovative Allocetra™ cell therapy platform. The technology aims to reset immune cells for treating inflammatory and autoimmune diseases. On the other hand, Unusual Machines, under CEO Allan Evans, is focusing on the drone industry, acquiring valuable IP and brands to cater to various sectors. The company's subsidiaries, Fat Shark and Rotor Riot, are leading in FPV products and services, positioning Unusual Machines for long-term growth.
Positive
Enlivex Therapeutics presents a unique investment opportunity in the biopharmaceutical sector with its innovative Allocetra™ cell therapy platform.
The company's technology targets resetting immune cells for treating inflammatory and autoimmune diseases with high unmet medical needs.
Unusual Machines is strategically growing in the drone industry by acquiring valuable IP and brands to serve a broad range of industries, including consumer, public safety, and drone delivery.
The company's subsidiaries, Fat Shark and Rotor Riot, are at the forefront of FPV products and services, poised to dominate the consumer FPV market and expand into new enterprise verticals.
03/22/2024 - 10:50 AM
ORLANDO, FL / ACCESSWIRE / March 22, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Unusual Machines Inc. (NYSE American:UMAC) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, March 23, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Access the interviews in their entirety at:
In an exclusive interview, Oren Hershkovitz, CEO of Enlivex Therapeutics, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide a corporate update. Enlivex presents a compelling investment opportunity in the biopharmaceutical sector with its innovative approach to treating life-threatening and debilitating conditions through macrophage reprogramming. The company's leading product, Allocetra™, is a groundbreaking, off-the-shelf cost-effective cell therapy platform designed to reset the body's immune cells (macrophages) to their optimal functioning state. This technology addresses a critical need for rebalancing the immune system, offering potential treatments for a range of inflammatory and autoimmune diseases with high unmet medical needs. With macrophages playing a vital role as the body's first line of defense, Enlivex's focus on converting these cells from a "disease setting" back to their "resolution settings" opens the door to addressing complex conditions like sepsis and osteoarthritis, tapping into multi-billion-dollar markets.
Allan Evans, CEO of Unusual Machines, appears on the RedChip Small Stocks, Big Money™ show on Bloomberg TV to provide a corporate update. Unusual Machines is gathering great teams, revenue generating customers, valuable IP, and high-quality brands, growing both organically and through strategic acquisitions within the highly fragmented drone industry. The Company is focused on investing in the development or acquisition of FPV products and services that serve a broad set of industries including consumer, public safety, and drone delivery. The Company's Fat Shark and Rotor Riot subsidiaries are setting the standard for FPV immersive experiences and are expected to continue to corner the consumer FPV market as Unusual Machines expands into new enterprise verticals over the next 24 months. As Unusual Machines capitalizes on the wealth of opportunities in the rapidly evolving drone market it is well positioned for long-term success.
About Enlivex Therapeutics
Enlivex is a clinical-stage macrophage reprogramming immunotherapy company developing AllocetraTM , a universal, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. Resetting non-homeostatic macrophages into their homeostatic state is critical for immune system rebalancing and resolution of life-threatening conditions. For more information, visit http://www.enlivex.com .
About Unusual Machines
Unusual Machines manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot e-commerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar US drone industry. According to Fact.MR, the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032.
For more information visit Unusual Machines at https://www.unusualmachines.com/ .
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 32 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™ , which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
To learn more about RedChip's products and services, please visit:
https://www.redchip.com/corporate/investor_relations
"Discovering Tomorrow's Blue Chips Today"™
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/ https://www.facebook.com/RedChipCompanies https://www.instagram.com/redchipcompanies/ https://twitter.com/RedChip https://www.youtube.com/@redchip https://rumble.com/c/c-3068340 https://www.redchip.com/newsletter/latest
Contact:
Dave Gentryinfo@redchip.com
SOURCE: RedChip Companies Inc.
press release on accesswire.com
The CEO of Enlivex Therapeutics is Oren Hershkovitz.
The CEO of Unusual Machines Inc. is Allan Evans.
The leading product of Enlivex Therapeutics is Allocetra™, a groundbreaking cell therapy platform.
Unusual Machines Inc. serves a broad set of industries including consumer, public safety, and drone delivery.
The subsidiaries of Unusual Machines Inc. are Fat Shark and Rotor Riot, leading in FPV products and services.
